Mayne Pharma Group Limited (MYX.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 6.83 |
| Open | 6.86 |
| Bid | 7.08 x 78655600 |
| Ask | 7.12 x 42535300 |
| Day's range | 6.85 - 7.18 |
| 52-week range | 2.75 - 7.40 |
| Volume | |
| Avg. volume | 214,969 |
| Market cap | 605.729M |
| Beta (5Y monthly) | 1.32 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 18 Jan 2023 |
| 1y target est | N/A |
- GlobeNewswire
Mayne Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
ADELAIDE, Australia, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Mayne Pharma Group Limited (ASX: MYX) today announced that Shawn Patrick O’Brien, Chief Executive Officer of Mayne Pharma, will present at the 42nd Annual J.P. Morgan Healthcare Conference as follows: Date: Thursday, January 11, 2024Time: 7:30am PST / 10:30 am ESTWebcast: Click here The live and archived webcast of the presentation will be accessible from the Company’s website www.maynepharma.com under Investor Relations. The replay of the w
© 2024 Yahoo. All rights reserved.